OM2 Stock Overview
Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Orthofix Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.60 |
| 52 Week High | US$18.60 |
| 52 Week Low | US$10.40 |
| Beta | 0.88 |
| 1 Month Change | -7.83% |
| 3 Month Change | -38.73% |
| 1 Year Change | -22.63% |
| 3 Year Change | -58.27% |
| 5 Year Change | -66.24% |
| Change since IPO | -43.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| OM2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.9% | 4.7% | 0.8% |
| 1Y | -22.6% | -8.9% | 14.6% |
Return vs Industry: OM2 underperformed the German Medical Equipment industry which returned -12.1% over the past year.
Return vs Market: OM2 underperformed the German Market which returned 14% over the past year.
Price Volatility
| OM2 volatility | |
|---|---|
| OM2 Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: OM2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: OM2's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 1,616 | Massimo Calafiore | orthofix.com |
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions.
Orthofix Medical Inc. Fundamentals Summary
| OM2 fundamental statistics | |
|---|---|
| Market cap | €428.72m |
| Earnings (TTM) | -€128.32m |
| Revenue (TTM) | €721.58m |
0.6x
P/S Ratio-3.3x
P/E RatioIs OM2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OM2 income statement (TTM) | |
|---|---|
| Revenue | US$804.53m |
| Cost of Revenue | US$252.08m |
| Gross Profit | US$552.45m |
| Other Expenses | US$695.52m |
| Earnings | -US$143.07m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.65 |
| Gross Margin | 68.67% |
| Net Profit Margin | -17.78% |
| Debt/Equity Ratio | 34.2% |
How did OM2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/16 09:37 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Orthofix Medical Inc. is covered by 19 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gregory Chodaczek | Boenning & Scattergood, Inc. |
| Michael Gorman | BTIG |
| Caitlin Cronin | Canaccord Genuity |